Mark Nehler
Concepts (406)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Arterial Disease | 32 | 2024 | 475 | 4.190 |
Why?
| | Ischemia | 30 | 2024 | 409 | 4.060 |
Why?
| | Lower Extremity | 21 | 2024 | 427 | 2.340 |
Why?
| | Internship and Residency | 17 | 2024 | 1147 | 2.310 |
Why?
| | Vascular Surgical Procedures | 25 | 2024 | 303 | 2.150 |
Why?
| | General Surgery | 10 | 2024 | 173 | 1.930 |
Why?
| | Rivaroxaban | 19 | 2024 | 255 | 1.930 |
Why?
| | Endovascular Procedures | 11 | 2024 | 312 | 1.600 |
Why?
| | Leg | 14 | 2007 | 236 | 1.460 |
Why?
| | Platelet Aggregation Inhibitors | 17 | 2024 | 463 | 1.420 |
Why?
| | Peripheral Vascular Diseases | 12 | 2022 | 103 | 1.320 |
Why?
| | Aspirin | 16 | 2024 | 387 | 1.240 |
Why?
| | Limb Salvage | 10 | 2024 | 57 | 1.000 |
Why?
| | Blood Vessel Prosthesis Implantation | 6 | 2023 | 202 | 1.000 |
Why?
| | Factor Xa Inhibitors | 9 | 2024 | 172 | 1.000 |
Why?
| | Surgeons | 4 | 2021 | 297 | 0.860 |
Why?
| | Femoral Artery | 10 | 2023 | 179 | 0.820 |
Why?
| | Arterial Occlusive Diseases | 7 | 2008 | 83 | 0.780 |
Why?
| | Education, Medical, Graduate | 6 | 2024 | 486 | 0.770 |
Why?
| | Treatment Outcome | 46 | 2024 | 10811 | 0.750 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2017 | 140 | 0.690 |
Why?
| | Career Choice | 4 | 2024 | 219 | 0.670 |
Why?
| | Risk Factors | 36 | 2025 | 10388 | 0.670 |
Why?
| | Popliteal Artery | 7 | 2023 | 59 | 0.660 |
Why?
| | Intermittent Claudication | 12 | 2022 | 118 | 0.660 |
Why?
| | Puerperal Disorders | 1 | 2020 | 31 | 0.650 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2020 | 77 | 0.640 |
Why?
| | Venous Thromboembolism | 4 | 2025 | 316 | 0.620 |
Why?
| | Personnel Selection | 3 | 2018 | 78 | 0.610 |
Why?
| | Thrombosis | 5 | 2024 | 371 | 0.600 |
Why?
| | Postoperative Complications | 12 | 2024 | 2654 | 0.590 |
Why?
| | Vascular System Injuries | 4 | 2021 | 71 | 0.590 |
Why?
| | Vascular Patency | 13 | 2023 | 106 | 0.580 |
Why?
| | Aged | 50 | 2025 | 23961 | 0.560 |
Why?
| | Time Factors | 21 | 2022 | 6828 | 0.550 |
Why?
| | Humans | 116 | 2025 | 137585 | 0.550 |
Why?
| | Risk Assessment | 16 | 2025 | 3457 | 0.540 |
Why?
| | Male | 74 | 2025 | 67762 | 0.530 |
Why?
| | Coronary Artery Disease | 5 | 2024 | 698 | 0.520 |
Why?
| | Quality Indicators, Health Care | 3 | 2016 | 307 | 0.500 |
Why?
| | Female | 69 | 2025 | 73304 | 0.500 |
Why?
| | Elective Surgical Procedures | 2 | 2017 | 179 | 0.490 |
Why?
| | Clinical Competence | 4 | 2022 | 1118 | 0.480 |
Why?
| | Mentors | 2 | 2020 | 202 | 0.470 |
Why?
| | Middle Aged | 51 | 2025 | 33479 | 0.460 |
Why?
| | Arteriovenous Shunt, Surgical | 2 | 2011 | 18 | 0.430 |
Why?
| | Angioplasty, Balloon | 3 | 2023 | 93 | 0.410 |
Why?
| | Renal Dialysis | 3 | 2013 | 435 | 0.400 |
Why?
| | Upper Extremity | 2 | 2011 | 99 | 0.400 |
Why?
| | Retrospective Studies | 27 | 2024 | 15657 | 0.390 |
Why?
| | Incidence | 10 | 2025 | 2804 | 0.380 |
Why?
| | Aged, 80 and over | 22 | 2024 | 7635 | 0.380 |
Why?
| | Paclitaxel | 3 | 2021 | 230 | 0.380 |
Why?
| | Patient Care Management | 1 | 2011 | 57 | 0.350 |
Why?
| | Kidney Failure, Chronic | 4 | 2013 | 570 | 0.340 |
Why?
| | Drug Therapy, Combination | 9 | 2024 | 1066 | 0.330 |
Why?
| | Alprostadil | 2 | 2007 | 32 | 0.330 |
Why?
| | Medicaid | 1 | 2014 | 435 | 0.320 |
Why?
| | Activities of Daily Living | 4 | 2006 | 413 | 0.320 |
Why?
| | Quality of Life | 6 | 2022 | 2892 | 0.310 |
Why?
| | Patient Readmission | 5 | 2023 | 697 | 0.310 |
Why?
| | Wound Healing | 5 | 2009 | 331 | 0.300 |
Why?
| | Continuity of Patient Care | 1 | 2011 | 284 | 0.300 |
Why?
| | Medicare | 1 | 2014 | 773 | 0.290 |
Why?
| | Adult | 33 | 2025 | 37929 | 0.290 |
Why?
| | Brain Ischemia | 2 | 2022 | 338 | 0.290 |
Why?
| | Drug-Eluting Stents | 2 | 2021 | 81 | 0.290 |
Why?
| | United States | 17 | 2025 | 14841 | 0.280 |
Why?
| | Kidney Diseases | 2 | 2011 | 408 | 0.280 |
Why?
| | Comorbidity | 7 | 2017 | 1622 | 0.270 |
Why?
| | Students, Medical | 2 | 2023 | 348 | 0.270 |
Why?
| | Ribs | 2 | 2016 | 35 | 0.260 |
Why?
| | Decision Support Techniques | 2 | 2021 | 421 | 0.260 |
Why?
| | Stroke | 3 | 2022 | 1120 | 0.260 |
Why?
| | Prodrugs | 1 | 2007 | 52 | 0.260 |
Why?
| | Computer Simulation | 1 | 2011 | 978 | 0.260 |
Why?
| | Critical Illness | 6 | 2020 | 811 | 0.260 |
Why?
| | Curriculum | 5 | 2024 | 992 | 0.260 |
Why?
| | Surveys and Questionnaires | 10 | 2024 | 5778 | 0.250 |
Why?
| | Myocardial Infarction | 3 | 2022 | 1046 | 0.250 |
Why?
| | Anticoagulants | 5 | 2025 | 664 | 0.250 |
Why?
| | Neoplasms | 1 | 2021 | 2671 | 0.250 |
Why?
| | Thoracic Outlet Syndrome | 2 | 2016 | 16 | 0.240 |
Why?
| | Software | 1 | 2011 | 665 | 0.240 |
Why?
| | Venous Thrombosis | 2 | 2025 | 190 | 0.240 |
Why?
| | Atherosclerosis | 2 | 2020 | 415 | 0.240 |
Why?
| | Catheterization, Peripheral | 2 | 2009 | 109 | 0.230 |
Why?
| | Hemorrhage | 7 | 2023 | 722 | 0.230 |
Why?
| | Attitude of Health Personnel | 3 | 2024 | 1171 | 0.230 |
Why?
| | Femoral Vein | 3 | 2008 | 34 | 0.230 |
Why?
| | Graft Occlusion, Vascular | 3 | 2011 | 40 | 0.230 |
Why?
| | Cardiovascular Surgical Procedures | 2 | 2001 | 30 | 0.230 |
Why?
| | Reoperation | 10 | 2014 | 573 | 0.230 |
Why?
| | Iliac Aneurysm | 2 | 2022 | 19 | 0.220 |
Why?
| | Carotid Stenosis | 2 | 1996 | 91 | 0.220 |
Why?
| | Parental Leave | 1 | 2024 | 26 | 0.220 |
Why?
| | Patient Care Team | 2 | 2024 | 631 | 0.210 |
Why?
| | Urology | 1 | 2024 | 63 | 0.210 |
Why?
| | Chi-Square Distribution | 3 | 2017 | 530 | 0.210 |
Why?
| | Ultrasonography, Doppler | 2 | 2021 | 124 | 0.210 |
Why?
| | Fibrinolytic Agents | 3 | 2022 | 270 | 0.210 |
Why?
| | Acute Disease | 4 | 2021 | 1007 | 0.210 |
Why?
| | Diabetes Complications | 3 | 2015 | 227 | 0.200 |
Why?
| | Cranial Nerve Injuries | 1 | 2023 | 5 | 0.200 |
Why?
| | Carotid Body Tumor | 1 | 2023 | 5 | 0.200 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2023 | 82 | 0.200 |
Why?
| | Double-Blind Method | 8 | 2024 | 1993 | 0.200 |
Why?
| | Academic Medical Centers | 3 | 2017 | 512 | 0.200 |
Why?
| | Antifibrinolytic Agents | 1 | 2023 | 51 | 0.200 |
Why?
| | Diabetic Foot | 2 | 2019 | 24 | 0.190 |
Why?
| | Pulmonary Embolism | 1 | 2025 | 226 | 0.190 |
Why?
| | Meditation | 1 | 2022 | 31 | 0.190 |
Why?
| | Tibial Arteries | 4 | 2008 | 12 | 0.190 |
Why?
| | Cholesterol, LDL | 1 | 2024 | 365 | 0.190 |
Why?
| | Thrombolytic Therapy | 1 | 2003 | 142 | 0.180 |
Why?
| | Blood Coagulation Disorders | 1 | 2023 | 173 | 0.180 |
Why?
| | Blood Vessel Prosthesis | 3 | 2022 | 127 | 0.180 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2023 | 131 | 0.180 |
Why?
| | Smoking Cessation | 2 | 2002 | 442 | 0.180 |
Why?
| | Faculty, Medical | 1 | 2024 | 283 | 0.180 |
Why?
| | Heparin | 3 | 2023 | 261 | 0.170 |
Why?
| | Hemostatic Techniques | 1 | 2001 | 46 | 0.170 |
Why?
| | Quality Improvement | 2 | 2022 | 1178 | 0.170 |
Why?
| | Outpatients | 1 | 2024 | 396 | 0.170 |
Why?
| | Specialties, Surgical | 2 | 2017 | 75 | 0.170 |
Why?
| | Hospital Departments | 1 | 2020 | 10 | 0.170 |
Why?
| | Aortic Diseases | 1 | 2001 | 119 | 0.170 |
Why?
| | Suture Techniques | 1 | 2001 | 122 | 0.170 |
Why?
| | Hyperlipidemias | 1 | 2001 | 120 | 0.160 |
Why?
| | Blood Pressure Determination | 1 | 2021 | 157 | 0.160 |
Why?
| | Forefoot, Human | 1 | 1999 | 1 | 0.160 |
Why?
| | Multivariate Analysis | 4 | 2019 | 1509 | 0.160 |
Why?
| | Toes | 1 | 1999 | 14 | 0.160 |
Why?
| | Mentoring | 1 | 2022 | 149 | 0.160 |
Why?
| | Aneurysm | 2 | 1997 | 31 | 0.160 |
Why?
| | Logistic Models | 3 | 2017 | 2074 | 0.160 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1266 | 0.160 |
Why?
| | Canagliflozin | 1 | 2019 | 10 | 0.160 |
Why?
| | Self Concept | 1 | 2021 | 253 | 0.150 |
Why?
| | Databases, Factual | 4 | 2017 | 1357 | 0.150 |
Why?
| | Counseling | 1 | 2002 | 391 | 0.150 |
Why?
| | Patient Selection | 4 | 2014 | 696 | 0.150 |
Why?
| | Clinical Clerkship | 1 | 2020 | 101 | 0.150 |
Why?
| | Walking | 4 | 2022 | 529 | 0.150 |
Why?
| | Drug Prescriptions | 1 | 2020 | 245 | 0.150 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 64 | 0.150 |
Why?
| | Chronic Disease | 6 | 2011 | 1793 | 0.150 |
Why?
| | Iatrogenic Disease | 1 | 1998 | 67 | 0.140 |
Why?
| | School Admission Criteria | 1 | 2018 | 27 | 0.140 |
Why?
| | Extremities | 2 | 2009 | 131 | 0.140 |
Why?
| | Blood Vessels | 2 | 1998 | 187 | 0.140 |
Why?
| | Arm | 2 | 2004 | 104 | 0.140 |
Why?
| | Exercise Therapy | 2 | 2001 | 443 | 0.140 |
Why?
| | Cardiovascular Diseases | 5 | 2024 | 2111 | 0.140 |
Why?
| | Odds Ratio | 3 | 2016 | 1070 | 0.140 |
Why?
| | Arteriosclerosis | 1 | 1997 | 88 | 0.140 |
Why?
| | Physician Executives | 1 | 2017 | 31 | 0.140 |
Why?
| | Follow-Up Studies | 9 | 2021 | 5131 | 0.140 |
Why?
| | Ultrasonography, Doppler, Duplex | 2 | 1996 | 43 | 0.140 |
Why?
| | Cost of Illness | 1 | 2019 | 308 | 0.140 |
Why?
| | Hospitalization | 2 | 2025 | 2199 | 0.130 |
Why?
| | Homocysteine | 1 | 1997 | 156 | 0.130 |
Why?
| | Subclavian Artery | 1 | 1997 | 28 | 0.130 |
Why?
| | Vascular Diseases | 2 | 2015 | 243 | 0.130 |
Why?
| | Diabetes Mellitus | 3 | 2021 | 1040 | 0.130 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 160 | 0.130 |
Why?
| | Incidental Findings | 1 | 2016 | 87 | 0.130 |
Why?
| | Endarterectomy, Carotid | 2 | 2013 | 49 | 0.130 |
Why?
| | Vascular Malformations | 1 | 2016 | 52 | 0.120 |
Why?
| | Burnout, Professional | 1 | 2022 | 442 | 0.120 |
Why?
| | Sepsis | 2 | 2016 | 617 | 0.120 |
Why?
| | Osteotomy | 1 | 2016 | 119 | 0.120 |
Why?
| | Survival Rate | 4 | 2021 | 1972 | 0.120 |
Why?
| | Popliteal Vein | 1 | 1994 | 4 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 4 | 2021 | 889 | 0.110 |
Why?
| | Interprofessional Relations | 1 | 2017 | 283 | 0.110 |
Why?
| | Multidetector Computed Tomography | 1 | 2014 | 39 | 0.110 |
Why?
| | Hypertension | 2 | 2001 | 1295 | 0.110 |
Why?
| | Disease Progression | 3 | 2014 | 2757 | 0.110 |
Why?
| | Multiple Trauma | 1 | 2014 | 100 | 0.110 |
Why?
| | Endarterectomy | 1 | 1993 | 6 | 0.110 |
Why?
| | Thoracotomy | 1 | 2014 | 75 | 0.110 |
Why?
| | Premedication | 1 | 1993 | 44 | 0.100 |
Why?
| | Bandages | 1 | 1993 | 37 | 0.100 |
Why?
| | Recurrence | 4 | 2014 | 1060 | 0.100 |
Why?
| | Recovery of Function | 3 | 2011 | 653 | 0.100 |
Why?
| | Surgery, Computer-Assisted | 1 | 2014 | 101 | 0.100 |
Why?
| | Program Evaluation | 1 | 2017 | 898 | 0.100 |
Why?
| | Ulnar Artery | 1 | 1992 | 2 | 0.100 |
Why?
| | Injury Severity Score | 3 | 2021 | 522 | 0.100 |
Why?
| | Ischemic Attack, Transient | 1 | 1993 | 65 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 1000 | 0.100 |
Why?
| | Life Tables | 3 | 1998 | 20 | 0.100 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1329 | 0.100 |
Why?
| | Research Design | 2 | 2009 | 1139 | 0.100 |
Why?
| | Radial Artery | 1 | 1992 | 68 | 0.090 |
Why?
| | Fingers | 1 | 1992 | 88 | 0.090 |
Why?
| | Stress, Psychological | 1 | 2020 | 1100 | 0.090 |
Why?
| | Predictive Value of Tests | 4 | 2021 | 2031 | 0.090 |
Why?
| | Renal Insufficiency | 1 | 2014 | 162 | 0.090 |
Why?
| | Angiography | 2 | 2024 | 207 | 0.090 |
Why?
| | Seasons | 1 | 2014 | 547 | 0.090 |
Why?
| | Research Personnel | 1 | 2013 | 173 | 0.090 |
Why?
| | Aorta, Thoracic | 1 | 2014 | 267 | 0.090 |
Why?
| | Thrombectomy | 2 | 2003 | 69 | 0.090 |
Why?
| | Oregon | 1 | 2011 | 74 | 0.090 |
Why?
| | Pregnancy | 2 | 2024 | 6763 | 0.090 |
Why?
| | Prognosis | 5 | 2021 | 4030 | 0.090 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2024 | 1477 | 0.090 |
Why?
| | Young Adult | 6 | 2021 | 13209 | 0.090 |
Why?
| | Efficiency | 1 | 2011 | 99 | 0.080 |
Why?
| | Arteries | 2 | 2022 | 269 | 0.080 |
Why?
| | Catheterization | 2 | 2003 | 179 | 0.080 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 306 | 0.080 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2009 | 30 | 0.080 |
Why?
| | Device Approval | 1 | 2009 | 21 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2021 | 3284 | 0.080 |
Why?
| | Hypoglycemic Agents | 1 | 2019 | 1291 | 0.080 |
Why?
| | Adolescent | 7 | 2023 | 21513 | 0.080 |
Why?
| | Registries | 3 | 2025 | 2035 | 0.080 |
Why?
| | Workload | 1 | 2011 | 167 | 0.080 |
Why?
| | Disability Evaluation | 1 | 2011 | 290 | 0.080 |
Why?
| | Safety | 1 | 2011 | 338 | 0.080 |
Why?
| | Coated Materials, Biocompatible | 2 | 2023 | 62 | 0.080 |
Why?
| | Risk Management | 3 | 2007 | 93 | 0.080 |
Why?
| | Axillary Vein | 1 | 2008 | 4 | 0.080 |
Why?
| | Skin | 1 | 1993 | 752 | 0.070 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2024 | 445 | 0.070 |
Why?
| | Saphenous Vein | 3 | 1998 | 35 | 0.070 |
Why?
| | Global Health | 2 | 2021 | 386 | 0.070 |
Why?
| | Radiography | 4 | 2015 | 822 | 0.070 |
Why?
| | Athletic Injuries | 1 | 2014 | 529 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2021 | 2057 | 0.070 |
Why?
| | Colorado | 3 | 2016 | 4565 | 0.070 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2021 | 191 | 0.070 |
Why?
| | Practice Guidelines as Topic | 2 | 2011 | 1587 | 0.070 |
Why?
| | Prevalence | 1 | 2014 | 2734 | 0.070 |
Why?
| | Biomedical Research | 1 | 2013 | 692 | 0.070 |
Why?
| | Brachial Artery | 1 | 2008 | 205 | 0.070 |
Why?
| | Family Practice | 2 | 2020 | 464 | 0.070 |
Why?
| | Iloprost | 1 | 2006 | 45 | 0.060 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2007 | 389 | 0.060 |
Why?
| | Prospective Studies | 5 | 2021 | 7604 | 0.060 |
Why?
| | Exercise Test | 3 | 2011 | 625 | 0.060 |
Why?
| | Regional Blood Flow | 2 | 1999 | 474 | 0.060 |
Why?
| | Carotid Artery, Internal | 2 | 1996 | 42 | 0.060 |
Why?
| | Sulfonic Acids | 1 | 2004 | 13 | 0.060 |
Why?
| | United States Department of Veterans Affairs | 1 | 2009 | 678 | 0.060 |
Why?
| | Thrombophilia | 1 | 2025 | 83 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2019 | 2531 | 0.060 |
Why?
| | Single-Blind Method | 2 | 2015 | 282 | 0.060 |
Why?
| | Acetates | 1 | 2004 | 99 | 0.050 |
Why?
| | Veins | 2 | 1995 | 63 | 0.050 |
Why?
| | Specialty Boards | 1 | 2024 | 36 | 0.050 |
Why?
| | Thromboplastin | 1 | 2023 | 74 | 0.050 |
Why?
| | Clinical Trials as Topic | 1 | 2008 | 1050 | 0.050 |
Why?
| | Atherectomy | 1 | 2023 | 37 | 0.050 |
Why?
| | Blood Pressure | 2 | 2021 | 1786 | 0.050 |
Why?
| | Physical Exertion | 1 | 2004 | 215 | 0.050 |
Why?
| | Survival Analysis | 2 | 2004 | 1325 | 0.050 |
Why?
| | Forecasting | 2 | 2001 | 389 | 0.050 |
Why?
| | Sexism | 1 | 2023 | 61 | 0.050 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2002 | 11 | 0.050 |
Why?
| | Preoperative Care | 2 | 2002 | 362 | 0.050 |
Why?
| | Numbers Needed To Treat | 1 | 2021 | 7 | 0.050 |
Why?
| | Societies, Medical | 2 | 2009 | 820 | 0.050 |
Why?
| | Morbidity | 1 | 2023 | 324 | 0.050 |
Why?
| | Off-Label Use | 1 | 2022 | 52 | 0.050 |
Why?
| | Mobility Limitation | 1 | 2022 | 61 | 0.050 |
Why?
| | Psychomotor Performance | 1 | 2004 | 309 | 0.050 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 2001 | 6 | 0.050 |
Why?
| | Frailty | 1 | 2024 | 170 | 0.040 |
Why?
| | Vascular Neoplasms | 1 | 2001 | 18 | 0.040 |
Why?
| | Cadaver | 1 | 2022 | 296 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2025 | 565 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 840 | 0.040 |
Why?
| | Angioplasty | 1 | 2001 | 47 | 0.040 |
Why?
| | Educational Measurement | 1 | 2024 | 289 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2004 | 696 | 0.040 |
Why?
| | Aneurysm, False | 1 | 2001 | 48 | 0.040 |
Why?
| | Tetrazoles | 1 | 2001 | 41 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 224 | 0.040 |
Why?
| | Mass Screening | 1 | 2009 | 1287 | 0.040 |
Why?
| | Equipment Failure | 1 | 2001 | 108 | 0.040 |
Why?
| | Habits | 1 | 2020 | 49 | 0.040 |
Why?
| | Heart Failure | 1 | 2014 | 2236 | 0.040 |
Why?
| | Physician's Role | 1 | 2002 | 211 | 0.040 |
Why?
| | Joint Dislocations | 1 | 2021 | 50 | 0.040 |
Why?
| | Stents | 2 | 2022 | 527 | 0.040 |
Why?
| | Arterial Pressure | 1 | 2021 | 126 | 0.040 |
Why?
| | Radiography, Interventional | 1 | 2001 | 116 | 0.040 |
Why?
| | Empathy | 1 | 2022 | 173 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2008 | 2828 | 0.040 |
Why?
| | Diagnostic Imaging | 3 | 2007 | 332 | 0.040 |
Why?
| | Internationality | 1 | 2020 | 155 | 0.040 |
Why?
| | Prosthesis Design | 1 | 2022 | 327 | 0.040 |
Why?
| | Knee Injuries | 1 | 2021 | 99 | 0.040 |
Why?
| | Toe Joint | 1 | 1999 | 4 | 0.040 |
Why?
| | Pulse | 1 | 1999 | 23 | 0.040 |
Why?
| | Proprotein Convertase 9 | 1 | 2020 | 73 | 0.040 |
Why?
| | Internal Medicine | 1 | 2002 | 265 | 0.040 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2024 | 394 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2001 | 201 | 0.040 |
Why?
| | Artificial Limbs | 1 | 2003 | 200 | 0.040 |
Why?
| | Pulsatile Flow | 1 | 1999 | 60 | 0.040 |
Why?
| | Metatarsal Bones | 1 | 1999 | 22 | 0.040 |
Why?
| | Debridement | 1 | 1999 | 81 | 0.040 |
Why?
| | Patient Education as Topic | 1 | 2024 | 766 | 0.040 |
Why?
| | Myocardial Revascularization | 1 | 2019 | 73 | 0.040 |
Why?
| | Arteriovenous Fistula | 1 | 1998 | 36 | 0.040 |
Why?
| | Catheters, Indwelling | 1 | 1998 | 91 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 2020 | 265 | 0.040 |
Why?
| | Postoperative Care | 1 | 2019 | 261 | 0.040 |
Why?
| | Intraoperative Complications | 1 | 1998 | 138 | 0.030 |
Why?
| | Purinergic P2Y Receptor Antagonists | 1 | 2018 | 66 | 0.030 |
Why?
| | Carotid Arteries | 1 | 2019 | 206 | 0.030 |
Why?
| | Coronary Disease | 1 | 2000 | 385 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2023 | 744 | 0.030 |
Why?
| | Knee Joint | 1 | 2021 | 409 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2020 | 1236 | 0.030 |
Why?
| | Diagnosis, Differential | 2 | 2014 | 1483 | 0.030 |
Why?
| | Neck | 1 | 1997 | 101 | 0.030 |
Why?
| | Age Factors | 1 | 2004 | 3295 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 816 | 0.030 |
Why?
| | Health Promotion | 1 | 2022 | 741 | 0.030 |
Why?
| | Cardiology | 1 | 2019 | 274 | 0.030 |
Why?
| | Risk | 1 | 2019 | 912 | 0.030 |
Why?
| | Blood Loss, Surgical | 1 | 2016 | 101 | 0.030 |
Why?
| | Fractures, Bone | 1 | 2021 | 380 | 0.030 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 86 | 0.030 |
Why?
| | Foot | 1 | 1996 | 96 | 0.030 |
Why?
| | Pain Measurement | 2 | 2009 | 521 | 0.030 |
Why?
| | Aortic Rupture | 1 | 1995 | 25 | 0.030 |
Why?
| | Aorta, Abdominal | 1 | 1995 | 46 | 0.030 |
Why?
| | Groin | 1 | 1994 | 9 | 0.030 |
Why?
| | Vaccination | 1 | 2023 | 1381 | 0.030 |
Why?
| | Carotid Artery, External | 1 | 1993 | 3 | 0.030 |
Why?
| | Orthopedic Equipment | 1 | 1993 | 5 | 0.030 |
Why?
| | Glasgow Coma Scale | 1 | 2014 | 186 | 0.030 |
Why?
| | Venous Insufficiency | 1 | 1993 | 12 | 0.030 |
Why?
| | Cerebral Revascularization | 1 | 1993 | 19 | 0.030 |
Why?
| | Prosthesis Failure | 1 | 1994 | 123 | 0.030 |
Why?
| | Operative Time | 1 | 2014 | 145 | 0.030 |
Why?
| | Carotid Artery, Common | 1 | 1993 | 36 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 1993 | 109 | 0.030 |
Why?
| | Ankle | 1 | 1993 | 60 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2691 | 0.030 |
Why?
| | Arteritis | 1 | 1993 | 28 | 0.030 |
Why?
| | Exercise | 1 | 2004 | 2057 | 0.020 |
Why?
| | Pressure | 1 | 1993 | 225 | 0.020 |
Why?
| | Longitudinal Studies | 2 | 1999 | 2844 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2016 | 307 | 0.020 |
Why?
| | Housing | 1 | 1993 | 146 | 0.020 |
Why?
| | Inflammation | 1 | 2023 | 2837 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1313 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 5742 | 0.020 |
Why?
| | Nursing Homes | 1 | 1993 | 181 | 0.020 |
Why?
| | Pain | 2 | 2009 | 756 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2011 | 56 | 0.020 |
Why?
| | Lung | 1 | 2004 | 4060 | 0.020 |
Why?
| | Pneumonia | 1 | 2016 | 639 | 0.020 |
Why?
| | Child | 2 | 2020 | 21935 | 0.020 |
Why?
| | Equipment Safety | 1 | 2009 | 37 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5472 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 1999 | 1809 | 0.020 |
Why?
| | Ligation | 1 | 2008 | 92 | 0.020 |
Why?
| | Illinois | 1 | 2008 | 43 | 0.020 |
Why?
| | Length of Stay | 1 | 2014 | 1215 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2008 | 70 | 0.020 |
Why?
| | Equipment Design | 1 | 2009 | 522 | 0.020 |
Why?
| | Cardiovascular Agents | 1 | 2009 | 159 | 0.020 |
Why?
| | Smoking | 1 | 2015 | 1627 | 0.020 |
Why?
| | Ulcer | 1 | 2007 | 33 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2009 | 240 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2008 | 245 | 0.020 |
Why?
| | Cerebral Arterial Diseases | 1 | 2007 | 47 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 740 | 0.010 |
Why?
| | Infusions, Intravenous | 1 | 2006 | 413 | 0.010 |
Why?
| | Drug Carriers | 1 | 2006 | 128 | 0.010 |
Why?
| | Sterol O-Acyltransferase | 1 | 2004 | 5 | 0.010 |
Why?
| | Acetamides | 1 | 2004 | 36 | 0.010 |
Why?
| | Reference Values | 1 | 2006 | 816 | 0.010 |
Why?
| | Cost-Benefit Analysis | 1 | 2007 | 591 | 0.010 |
Why?
| | Hemodynamics | 1 | 2009 | 1113 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 786 | 0.010 |
Why?
| | Hyperemia | 1 | 2004 | 49 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2004 | 413 | 0.010 |
Why?
| | Ultrasonography | 1 | 2006 | 759 | 0.010 |
Why?
| | Treatment Refusal | 1 | 2002 | 89 | 0.010 |
Why?
| | Lipids | 1 | 2006 | 672 | 0.010 |
Why?
| | Sulfonamides | 1 | 2004 | 513 | 0.010 |
Why?
| | World Health Organization | 1 | 2000 | 123 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 2000 | 213 | 0.010 |
Why?
| | Heart Function Tests | 1 | 2000 | 59 | 0.010 |
Why?
| | Algorithms | 1 | 2007 | 1704 | 0.010 |
Why?
| | Aneurysm, Ruptured | 1 | 1998 | 35 | 0.010 |
Why?
| | Epoprostenol | 1 | 1999 | 136 | 0.010 |
Why?
| | Models, Theoretical | 1 | 2000 | 578 | 0.010 |
Why?
| | Gangrene | 1 | 1996 | 10 | 0.010 |
Why?
| | Patient Satisfaction | 1 | 2000 | 660 | 0.010 |
Why?
| | Embolization, Therapeutic | 1 | 1998 | 229 | 0.010 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 1995 | 39 | 0.010 |
Why?
| | Health Status | 1 | 2000 | 792 | 0.010 |
Why?
| | Behcet Syndrome | 1 | 1993 | 18 | 0.010 |
Why?
| | Takayasu Arteritis | 1 | 1993 | 16 | 0.010 |
Why?
| | Infant, Newborn | 1 | 1999 | 6079 | 0.000 |
Why?
|
|
Nehler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|